It is currently MHRA and NICE approved for treating bladder pain (interstitial cystitis of the bladder) , so it can be repurposed as an osteoarthritis treatment
Already in effect (January 1, 2026): Standard PA decisions within 7 calendar days (down from 14) Urgent PA decisions within 72 hours Specific denial reasons required on every denial (not just not medically necessary) Applies to Medicare Advantage, Medicaid managed care, CHIP, and ACA Marketplace plans Coming March 31, 2026: Payers must publicly report PA metrics for calendar year 2025: approval/denial rates, average decision times, and appeals outcomes Providers will be able to compare payer performance for the first time Coming January 1, 2027: FHIR-based Prior Authorization APIs required providers check PA requirements, submit requests, and receive decisions electronically through their EHR Expected to reduce average PA processing time from days to minutes for standard requests Medicare WISeR Model (live in AZ and WA): The Wasteful and Inappropriate Services Reduction pilot launched January 2026 in six states including Arizona and Washington
Many athletes use peptide therapy for recovery, injury healing, and performance optimization
[DOI] [PubMed] [Google Scholar] 17.O'Dowd JA, Lehoang DM, Butler RR, Dewitt DO, Mirzayan R: Operative treatment of acute patellar tendon ruptures
will try to follow in the footsteps of Acadia Pharmaceuticals Inc
No published Phase I trial establishing tolerability, human pharmacokinetics or dose escalation was identified
